CA
ORMP icon

Commerzbank Aktiengesellschaft’s Oramed Pharmaceuticals ORMP Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,500
Closed -$126K – 1184
2014
Q3 		$126K Sell
15,500
-1,500
-9% -$13.3K ﹤0.01% 1100
2014
Q2 		$164K Buy
+17,000
New +$174K ﹤0.01% 1150

Other funds holding ORMP

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ORMP Position: Q4 2014 in Review

Commerzbank Aktiengesellschaft sold out of Oramed Pharmaceuticals (ORMP) in Q4 2014, closing a stake of 15,500 shares — an estimated $126K sold.

Commerzbank Aktiengesellschaft first reported a position in ORMP in Q2 2014 and held it in 2 quarters. The position peaked at $164K in Q2 2014. 22 funds tracked by Wall St. Rank hold ORMP as of Q4 2014.

  • Commerzbank Aktiengesellschaft reported no remaining Oramed Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 15,500 Oramed Pharmaceuticals shares in Q4 2014, an estimated $126K.
  • Commerzbank Aktiengesellschaft first reported a position in Oramed Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Commerzbank Aktiengesellschaft's Oramed Pharmaceuticals position peaked at $164K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q4 2014.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2014, filed 5 Feb 2015.